-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QJWxToHZ0wKd1LfY/G+AuknyosfCHlHS/Bl1LObP9+2LXlY5icJvna+1PfO04Fmp 2I26ziZ4HrK1GHkZdYNcag== 0001193125-05-201762.txt : 20051014 0001193125-05-201762.hdr.sgml : 20051014 20051014155017 ACCESSION NUMBER: 0001193125-05-201762 CONFORMED SUBMISSION TYPE: 425 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051014 DATE AS OF CHANGE: 20051014 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALGORX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001139029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 425 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51146 FILM NUMBER: 051138920 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE STREET 2: 2ND FLOOR CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 201-325-6900 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE STREET 2: 2ND FLOOR CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: NOCICEPTECH PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010423 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CORGENTECH INC CENTRAL INDEX KEY: 0001131517 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770503399 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 425 BUSINESS ADDRESS: STREET 1: 650 GATEWAY BOULEVARD STREET 2: -- CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6506249600 MAIL ADDRESS: STREET 1: 650 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 425 1 d425.htm FILED PURSUANT TO RULE 425 Filed pursuant to Rule 425

Filed by Corgentech Inc. Pursuant to Rule 425

Under the Securities Act of 1933

And Deemed Filed Pursuant to Rule 14a-12

Under the Securities Exchange Act of 1934

Subject Company: AlgoRx Pharmaceuticals, Inc.

Commission File No. of Subject Company: 000-51146

 

*** *** ***

 

The following is an invitation for an analyst/investor luncheon sent to investors on October 14, 2005.

 

You are cordially invited to attend an analyst / investor luncheon next Friday with AlgoRx and Corgentech management for a review of clinical data from multiple trials of ALGRX 3268 and ALGRX 4975 and for a discussion of the marketing opportunities for these promising products.

 

WHEN: Friday, October 21st, 2005 - 11:30am - 1:30pm

 

     11:30am—Registration begins

 

     12:00pm—Webcast program begins

 

WHERE: Helmsley Park Lane Hotel

 

     36 Central Park South, New York

 

WHAT TO EXPECT:

 

     — Clinical data review for ALGRX 3268 and ALGRX 4975

 

     — Marketing opportunities for ALGRX 3268 and ALGRX 4975

 

     — Review of proposed merger between AlgoRx and Corgentech

 

     — Q&A with management of AlgoRx and Corgentech

 

     — Plated lunch to be served during webcast presentation

 

RSVP: Jennifer Williams

 

     williams@corgentech.com OR 650-246-6963

 

Please RSVP by Tuesday, October 18th, at 6pm

 

We hope you will be able to join us, but in the event that you can not, you may access the live webcast or the webcast replay through the Investor Information page of our website, www.corgentech.com.

-----END PRIVACY-ENHANCED MESSAGE-----